Merrimack Pharmaceuticals Inc. sell StockNews.com
Start price
24.06.23
/
50%
€3.98
Target price
24.06.24
-
Performance (%)
-
End price
25.06.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Merrimack Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 2,59 % | 2,47 % | 8,84 % | 55,55 % |
| iShares Nasdaq 100 | -0,91 % | -6,46 % | 24,93 % | 73,04 % |
| iShares Nikkei 225® | 0,15 % | -8,77 % | 47,39 % | 63,78 % |
| iShares S&P 500 | -0,37 % | -1,22 % | 21,67 % | 61,03 % |
Comments by StockNews_com for this prediction
In the thread Merrimack Pharmaceuticals Inc. diskutieren
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for MACK provided by MarketBeat
In the thread Trading Merrimack Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Merrimack Pharmaceuticals Inc.
Merrimack Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.98
08.07.23
08.07.23
-
08.07.24
08.07.24
-
09.07.24
09.07.24
